74 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
hereby, including without limitation (i) all expenses incident to the issuance and delivery of the Shares (including all printing and engraving costs … of the Agent’s participation in the offering and distribution of the Shares; (viii) the filing fees incident to FINRA review, if any; (ix) all fees
424B3
wcqk530m kdvrx8vo
27 May 22
Prospectus supplement
9:01am
8-K
EX-10.1
jbq9zy dbyf28t
2 May 22
Tempest Announces Private Placement Financing of $15 Million
8:02am
8-K
EX-10.2
yz582
2 May 22
Tempest Announces Private Placement Financing of $15 Million
8:02am
8-K
EX-3.1
m9hm 0d3j1qj5gr13d4l
24 Sep 21
Amendments to Articles of Incorporation or Bylaws
11:03am
8-K
EX-1.1
50lhwbpn2ksprzf88d5
23 Jul 21
Other Events
5:20pm
8-K
EX-99.2
w14nvtwejpf0
16 Jul 21
Other Events
4:31pm